Skip to main content
DongKoo Bio & Pharma Co., Ltd. logo

DongKoo Bio & Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 006620 ISIN · KR7006620009 KO Manufacturing
Open in API
Filings indexed 209 across all filing types
Latest filing 2025-07-02 M&A Activity
Country KR South Korea
Listing KO 006620

About DongKoo Bio & Pharma Co., Ltd.

https://www.dongkoo.com/eng/

DongKoo Bio & Pharma Co., Ltd. is a biopharmaceutical company that manufactures and sells a range of pharmaceuticals and health supplements. The company holds a leading position in the dermatology prescription market, with a product portfolio that includes antihistamines, analgesics, antipyretics, and digestants. Strategically expanding beyond traditional pharmaceuticals, DongKoo Bio & Pharma is focused on the biotechnology sector, particularly the development of stem cell-based therapies. This growth is pursued through an "Open Innovation" model to build a pipeline of differentiated products, supported by its research centers and PIC/s compliant GMP manufacturing facilities.

Recent filings

Filing Released Lang Actions
합병등종료보고서(합병)
M&A Activity Classification · 1% confidence The document is a 'Report on the Completion of Merger' (합병등종료보고서) filed with the Financial Supervisory Service (금융감독원). It details the finalization of a merger between Dongkoo Bio & Pharma and C&Wise, including the merger schedule, financial impact, and confirmation that no new shares were issued. This falls under M&A activity documentation.
2025-07-02 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (Cho Yong-joon and related parties) in Dongkoo Bio & Pharma. This type of filing is specifically categorized as a 'Major Shareholding Notification' (MRQ) in the provided schema.
2025-06-18 Korean
분기보고서 (2025.03)
Interim / Quarterly Report Classification · 1% confidence The document is a '분기보고서' (Quarterly Report) for Dongkoo Bio & Pharma, covering the period from January 1, 2025, to March 31, 2025. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2025
2025-05-15 Korean
주요사항보고서(회사합병결정)
M&A Activity Classification · 1% confidence The document is a 'Major Matter Report' (주요사항보고서) filed with the Korean Financial Supervisory Service/Korea Exchange regarding a merger decision (회사합병 결정) between DongKoo Bio & Pharma and its subsidiary C&Wise. It details the merger method, purpose, financial impact, and timeline. This falls under M&A activity (merger proposals/takeover bids).
2025-04-30 Korean
주주명부폐쇄기간또는기준일설정
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from Dongkoo Bio & Pharma regarding the setting of a record date for shareholder list closure. The purpose is to identify shareholders for the purpose of expressing dissent regarding a small-scale merger with C&Wise. Since this is a regulatory announcement regarding corporate actions (merger-related record date) that does not fit into specific categories like M&A activity (which would be the merger announcement itself) or dividend notices, it falls under the general regulatory filing category.
2025-04-30 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 1% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details changes in share ownership, specifically regarding collateral agreements (stock-backed loans) by the major shareholder and related parties of Dongkoo Bio & Pharma. This falls under the category of Major Shareholding Notification.
2025-04-23 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.